BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License
PHILADELPHIA and VANCOUVER, British Columbia, Feb. 18, 2026 (GLOBE NEWSWIRE) -- BriaCell…
DerivaDEX LAUNCHES ITS LICENSED DERIVATIVES TRADING PLATFORM, MARKING THE FIRST DAO-GOVERNED DEFI EXCHANGE TO OPERATE WITH A REGULATORY LICENSE
HAMILTON, Bermuda, Feb. 17, 2026 /PRNewswire/ -- DerivaDEX today announced the launch of…
FDA Accepts LEQEMBI IQLIK (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimers Disease under Priority Review
If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment…
Etienna Bio Secures Exclusive Worldwide License from UMass Chan Medical School for Novel Adipose-Derived Regenerative Platform
LEAWOOD, Kan., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Etienna Bio, Inc., a…
Valneva and Serum Institute of India Announce Discontinuation of Chikungunya Vaccine License Agreement
Saint-Herblain (France), Pune, (India), December 31, 2025 – Valneva SE (“Valneva” or…
Weebit Nano secures a license agreement with Texas Instruments
HOD HASHARON, Israel, Dec. 28, 2025 (GLOBE NEWSWIRE) -- Weebit Nano Limited…
KuCoin EU Secures MiCAR License to Deliver Regulated Digital Asset Services In Europe
VIENNA, Austria, Nov. 28, 2025 /PRNewswire/ -- KuCoin, a leading global crypto platform…
Vera Therapeutics Submits Biologics License Application to U.S. FDA through Accelerated Approval Program for Atacicept for the Treatment of Adults with IgA Nephropathy
Atacicept received FDA Breakthrough Therapy Designation for the treatment of IgANORIGIN Phase…
Bahrain’s Golden License Strikes Gold: USD 4.4 Billion Inflows Revealed at Gateway Gulf Showcasing the Island Nation’s Global Investment Appeal
The latest batch of Golden Licenses span across diversified sectors namely tech,…
Alvotech Provides Update on the Status ofU.S. Biologics License Application for AVT05
REYKJAVIK, Iceland, Nov. 02, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a…
